Request Deal Involvement
OrbiMed, Novo Holdings and Jeito Capital led a $181.4m Series D in Alentis Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
O Public Relations
legal advisors
Cooley
or
Principals
bidder
INNOBIO
bidder
MORNINGSIDE VENTURE CAPITAL
bidder
NOVO HOLDINGS A/S
bidder
JEITO CAPITAL
bidder
BPIFRANCE INVESTISSEMENT
bidder
FRAZIER LIFE SCIENCES
bidder
AVEGO BIOSCIENCE CAPITAL
target
ALENTIS THERAPEUTICS
bidder
RA CAPITAL MANAGEMENT
bidder
ORBIMED ADVISORS LLC
bidder
LONGITUDE CAPITAL MANAGEMENT CO LLC
bidder
CATALIO CAPITAL MANAGEMENT
bidder
PIPER HEARTLAND HEALTHCARE CAPITAL
bidder
PUREOS BIOVENTURES
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite